Diabetic peripheral arterial disease in COVID‑19 pandemic

Creative Commons License

Ekim M., Ekim H., Akarsu G. D.

JOURNAL OF RESEARCH IN MEDICAL SCIENCES, vol.29, no.1, pp.1-8, 2024 (SCI-Expanded)

  • Publication Type: Article / Article
  • Volume: 29 Issue: 1
  • Publication Date: 2024
  • Doi Number: 10.4103/jrms.jrms_509_23
  • Journal Name: JOURNAL OF RESEARCH IN MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, Directory of Open Access Journals
  • Page Numbers: pp.1-8
  • Yozgat Bozok University Affiliated: Yes

Abstract

Both diabetes and peripheral arterial disease (PAD) have complex interactions with COVID‑19. PAD is one of the most important underlying factors in the development of diabetic foot. The COVID‑19 pandemic has also caused an increase in cardiovascular complications in those with chronic diseases, including diabetics, due to both the thrombophilic course of the viral disease and the lockdown measures applied for prevention. Since both COVID‑19 and diabetes mellitus predispose to thrombosis, PAD is likely to have a more severe course in diabetic patients with COVID‑19. The aim of our study is to discuss the complications, prophylaxis, and treatment of PAD, which is a serious complication of diabetes, during the pandemic period.